Skip to main content
Signal8

Crutcher Patrick J

SEC insider (Form 3/4/5 filer). CIK 0001754540. Director at Jasper Therapeutics, Inc. (JSPR) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in REDWOOD CITY, CA.

Companies Crutcher Patrick J has filed insider reports for

  • Jasper Therapeutics, Inc. (JSPR): Director
  • Amanat Acquisition Corp. (AMAN): Director
Crutcher Patrick J profile photo

Crutcher Patrick J

CIK: 0001754540

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Director
Amanat Acquisition Corp. logo
AMAN

Amanat Acquisition Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 31, 2026
    Award

    Stock Option (Right to Buy

    Direct
    7.5K shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 20, 2026
    Purchase

    Non-Voting Convertible Preferred Stock

    Direct
    888 shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 16, 2026
    Award

    Stock Option (Right to Buy

    Direct
    15K shares-

1-3 of 3